Session: FRI 368-390-Metabolic Bone Disease Case Reports (posters)
Poster Board FRI 383
Clinical case: We have sequenced all exons and intron–exon boundaries of the PHEX gene of all family members. Clinical features include, Short statue, bowing of leg,difficulty walking teeth abnormalities, and variable serum phosphate level in patients of this family. Herein ,we also identified a novel missense mutation at exon 4 (c.422 C > T) in proband and his family members, four family members had a heterozygous mutation, and the proband had a hemizygous mutation, The mutation c.422C>T were predicted to be probably damaging when used PolyPhen-2 software. The residues Ser141 were shown to be perfectly conserved among humans, mice, rats, cow and chicken. Another striking clinical feature of this family, with a documented mutation of the PHEX gene, was the coexistence of type 1 diabetes in proband which is never reported before.
Conclusion: XLH in our patient is caused by a novel mutation within exon 4 of the PHEX gene. This is the first report of a de novo mutation of PHEX in a type 1 diabetes patient, and heterozygous mutation in the other family member did not appear to influence blood glucose homeostasis.
Nothing to Disclose: CF, ZM, YH, HG, JH
*Please take note of The Endocrine Society's News Embargo Policy at https://www.endocrine.org/news-room/endo-annual-meeting/pr-resources-for-endo
See more of: Abstracts - Orals, Poster Previews, and Posters